BOQIJONOVA , Nargizaxon. Improvement of Secondary Prevention after Coronary Stenting in Patients with Ischemic Heart Disease: Assessment of Medication Adherence and Cardiovascular Risk Factors. International Journal of Medical and Clinical Sciences, [S. l.], v. 1, n. 4, p. 432–439, 2026. Disponível em: https://journalmed.org/index.php/ijctm/article/view/111. Acesso em: 9 jun. 2026.